Therefore, the suppression of an autoinhibitory mechanism through the conformational change effected by interacting with integrin αvβ5 and phosphorylation by EGFR-MAP4K4 signaling might, in turn, regulate FARP1 activity in gastric cancer cells. The gene discussed is EGFR; the disease is gastric cancer.